Bicalutamide plus Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotoxicosis: A Phase II, Open-Label Pilot Study (BATT)

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pediatric Endocrinology & Metabolism (JPEM)

• Publication date

  2010-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1515/jpem.2010.161PMID 21158211
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.

  2009cited by this paper
• Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.

  2008cited by this paper
• Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial.

  2008cited by this paper
• Long‐term treatment of familial male‐limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole

  2008cited by this paper
• The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.

  2008cited by this paper
• Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer

  2006cited by this paper
• Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.

  2006cited by this paper
• Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

  2006cited by this paper
• Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial.

  2006cited by this paper
• Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty.

  2005cited by this paper
• Testotoxicosis: current viewpoint.

  2005cited by this paper
• An Open Label 12-Month Pilot Trial on the Effects of the Aromatase Inhibitor Anastrozole in Growth Hormone (GH)-Treated GH Deficient Adolescent Boys

  2004cited by this paper
• Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.

  2004cited by this paper
• Association of testosterone and dihydrotestosterone with externalizing behavior in adolescent boys and girls.

  2003cited by this paper
• Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor positive advanced breast carcinoma

  2001cited by this paper
• Anastrozole Is Superior to Tamoxifen as First-Line Therapy in Hormone Receptor Positive Advanced Breast Carcinoma Results of Two Randomized Trials Designed for Combined Analysis

  2001cited by this paper
• Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback.

  2000cited by this paper
• Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup.

  2000cited by this paper
• The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary–gonadal axis in both sexes

  2000cited by this paper
• Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset.

  1999cited by this paper
• Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.

  1998cited by this paper
• Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma

  1998cited by this paper
• Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate.

  1996cited by this paper
• Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty.

  1995cited by this paper
• Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin.

  1993cited by this paper
• A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

  1993cited by this paper
• Treatment of familial male precocious puberty with spironolactone and testolactone.

  1989cited by this paper
• Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy.

  1985cited by this paper
• Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.

  1983cited by this paper

• Bicalutamide does not raise transaminases clinically significantly compared to alternative anti-androgen regimens among transfeminine adolescents and young adults: A retrospective cohort study.

  2025cites this paper
• Bicalutamide: A review

  2024cites this paper
• A Rare Cause of Precocious Puberty - Testotoxicosis

  2024cites this paper
• Presentation and Care for Children with Peripheral Precocious Puberty.

  2024cites this paper
• Bicalutamide does not raise transaminases in comparison to alternative anti-androgen regimens among transfeminine adolescents and young adults: a retrospective cohort study

  2024cites this paper
• Placing a Report of Bicalutamide-Induced Hepatotoxicity in the Context of Current Standards of Care for Transgender Adolescents.

  2024cites this paper
• Anastrozole - off­‑label use in men

  2023cites this paper
• A retrospective review of the use of bicalutamide in transfeminine youth; a single center experience.

  2023cites this paper
• Long-Term Treatment With Letrozole in a Boy With Familial Male-Limited Precocious Puberty

  2022cites this paper
• Case report: Fluctuating tumor markers in a boy with gonadotropin-releasing hormone-independent precocious puberty induced by a pineal germ cell tumor

  2022cites this paper
• Early Puberty.

  2022cites this paper
• Familial Male-limited Precocious Puberty (FMPP) and Testicular Germ Cell Tumors

  2022cites this paper
• Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function LHCGR Variant.

  2022cites this paper
• Management of cardiometabolic complications in polycystic ovary syndrome: Unmet needs

  2021cites this paper
• Клинические рекомендации «Преждевременное половое развитие»

  2021cites this paper
• Gender Care

  2021cites this paper
• Testotoxicosis without Testicular Mass: Revealed by Peripheral Precocious Puberty and Confirmed by Somatic LHCGR Gene Mutation

  2020influential citation
• Growing Up Fast: Managing Autism Spectrum Disorder and Precocious Puberty.

  2020cites this paper
• Precocious puberty

  2020cites this paper
• Quality of Life in Adolescent Boys with Idiopathic Short Stature: Positive Impact of Growth Hormone and Aromatase Inhibitors

  2019cites this paper
• Bicalutamide as an Androgen Blocker With Secondary Effect of Promoting Feminization in Male-to-Female Transgender Adolescents.

  2019cites this paper
• Diseases caused by mutations in luteinizing hormone/chorionic gonadotropin receptor.

  2019cites this paper
• Idiopathic gonadotropin-independent precocious puberty – is regular surveillance required?

  2019cites this paper
• TESTOTOXICOSIS WITH AN EPISODIC COURSE: AN UNUSUAL CASE WITHIN A SERIES.

  2019cites this paper
• Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes.

  2019cites this paper
• Disorders of Puberty: Pharmacotherapeutic Strategies for Management.

  2019cites this paper
• Adult height in patients with familial male-limited precocious puberty and the role of an aromatase inhibitor in patient management

  2018cites this paper
• Central precocious puberty in a case of late-diagnosed familial testotoxicosis and long-term treatment monitoring

  2018cites this paper
• Male Puberty: What Is Normal and Abnormal?

  2017cites this paper
• Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin‐releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty

  2017cites this paper
• Aromatase Inhibitors in the Treatment of Short Stature.

  2016cites this paper
• Treatment of Peripheral Precocious Puberty.

  2016cites this paper
• Hyperplasia in glands with hormone excess.

  2016cites this paper
• Chapter 121 – Precocious Puberty∗

  2016cites this paper
• Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene

  2015cites this paper
• Letter to the Editor regarding “Testotoxicosis: Report of Two Cases, One with a Novel Mutation in Luteinizing Hormone/Choriogonadotropin Receptor Gene”

  2015cites this paper
• Novel approaches to short stature therapy.

  2015cites this paper
• Aromatase Inhibitors in Paediatric Endocrinology

  2015cites this paper
• Aromatase inhibitors for short stature in male children and adolescents.

  2015cites this paper
• Treatment and outcomes of precocious puberty: an update.

  2013cites this paper
• Aromatase inhibitors in pediatrics

  2012cites this paper
• [Peripheral precocious puberty: clinical, diagnostic and therapeutical principles].

  2012cites this paper
• Pubertad precoz periférica: fundamentos clínicos y diagnóstico-terapéuticos

  2012cites this paper
• Aromatase inhibitors in men: effects and therapeutic options

  2011cites this paper
• The Use of Bone Age in Clinical Practice – Part 2

  2011cites this paper
• Pubertà precoce: quando e come trattare

  2011cites this paper
• El Uso de la Edad Ósea en la Práctica Clínica - Parte 1

  2011cites this paper
• The Use of Bone Age in Clinical Practice – Part 1

  2011cites this paper
• Aromatase inhibitors in men: effects and therapeutic options

  2011cites this paper
• Strategies for maximizing growth in puberty in children with short stature.

  2011cites this paper
• Strategies for maximizing growth in puberty in children with short stature.

  2009cites this paper
• Endocrinology and diabetes

  2002cites this paper